Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
This marks a meaningful step in the company's continued expansion in the region
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
Call it a major breakthrough for diagnostic imaging
Subscribe To Our Newsletter & Stay Updated
